GnRH antagonists (Neurocrine/AbbVie)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameGnRH antagonists (Neurocrine/AbbVie)
Drug Alias NameGnRH antagonists (Neurocrine/AbbVie)GnRH antagonists (Neurocrine/Abbott)FW-536FW-568FW-606 +[6] 
ClassificationSmall molecules
Mechanisms of ActionGonadotropin-releasing hormone receptor antagonists
TargetsGonadotropin-releasing hormone receptor
Therapy Area/IndicationsUterine FibroidsEndometriosisInfertility +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNeurocrine Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAbbott LaboratoriesAbbvie IncNeurocrine Biosciences Inc
Active IndicationsN/A
Inactive IndicationsUterine FibroidsEndometriosisInfertility +[5] 

Other Information

ATC CodeN/A
Related LinksN/A